229 related articles for article (PubMed ID: 15294983)
1. Mycobacterium tuberculosis LprG (Rv1411c): a novel TLR-2 ligand that inhibits human macrophage class II MHC antigen processing.
Gehring AJ; Dobos KM; Belisle JT; Harding CV; Boom WH
J Immunol; 2004 Aug; 173(4):2660-8. PubMed ID: 15294983
[TBL] [Abstract][Full Text] [Related]
2. Alternate class I MHC antigen processing is inhibited by Toll-like receptor signaling pathogen-associated molecular patterns: Mycobacterium tuberculosis 19-kDa lipoprotein, CpG DNA, and lipopolysaccharide.
Tobian AA; Potter NS; Ramachandra L; Pai RK; Convery M; Boom WH; Harding CV
J Immunol; 2003 Aug; 171(3):1413-22. PubMed ID: 12874233
[TBL] [Abstract][Full Text] [Related]
3. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis.
Noss EH; Pai RK; Sellati TJ; Radolf JD; Belisle J; Golenbock DT; Boom WH; Harding CV
J Immunol; 2001 Jul; 167(2):910-8. PubMed ID: 11441098
[TBL] [Abstract][Full Text] [Related]
4. Recombinant Lipoprotein Rv1016c Derived from
Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
[TBL] [Abstract][Full Text] [Related]
5. Prolonged toll-like receptor signaling by Mycobacterium tuberculosis and its 19-kilodalton lipoprotein inhibits gamma interferon-induced regulation of selected genes in macrophages.
Pai RK; Pennini ME; Tobian AA; Canaday DH; Boom WH; Harding CV
Infect Immun; 2004 Nov; 72(11):6603-14. PubMed ID: 15501793
[TBL] [Abstract][Full Text] [Related]
6. The Mycobacterium tuberculosis 19-kilodalton lipoprotein inhibits gamma interferon-regulated HLA-DR and Fc gamma R1 on human macrophages through Toll-like receptor 2.
Gehring AJ; Rojas RE; Canaday DH; Lakey DL; Harding CV; Boom WH
Infect Immun; 2003 Aug; 71(8):4487-97. PubMed ID: 12874328
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
[TBL] [Abstract][Full Text] [Related]
8. Conserved mycobacterial lipoglycoproteins activate TLR2 but also require glycosylation for MHC class II-restricted T cell activation.
Sieling PA; Hill PJ; Dobos KM; Brookman K; Kuhlman AM; Fabri M; Krutzik SR; Rea TH; Heaslip DG; Belisle JT; Modlin RL
J Immunol; 2008 May; 180(9):5833-42. PubMed ID: 18424702
[TBL] [Abstract][Full Text] [Related]
9. Bacterial heat shock proteins enhance class II MHC antigen processing and presentation of chaperoned peptides to CD4+ T cells.
Tobian AA; Canaday DH; Harding CV
J Immunol; 2004 Oct; 173(8):5130-7. PubMed ID: 15470057
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis PPE18 protein inhibits MHC class II antigen presentation and B cell response in mice.
Dolasia K; Nazar F; Mukhopadhyay S
Eur J Immunol; 2021 Mar; 51(3):603-619. PubMed ID: 33084017
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of a Toll-like receptor antagonist on Mycobacterium tuberculosis-induced macrophage responses.
Means TK; Jones BW; Schromm AB; Shurtleff BA; Smith JA; Keane J; Golenbock DT; Vogel SN; Fenton MJ
J Immunol; 2001 Mar; 166(6):4074-82. PubMed ID: 11238656
[TBL] [Abstract][Full Text] [Related]
12. Mycobacterium tuberculosis LprA is a lipoprotein agonist of TLR2 that regulates innate immunity and APC function.
Pecora ND; Gehring AJ; Canaday DH; Boom WH; Harding CV
J Immunol; 2006 Jul; 177(1):422-9. PubMed ID: 16785538
[TBL] [Abstract][Full Text] [Related]
13. The 19-kDa Mycobacterium tuberculosis protein induces macrophage apoptosis through Toll-like receptor-2.
López M; Sly LM; Luu Y; Young D; Cooper H; Reiner NE
J Immunol; 2003 Mar; 170(5):2409-16. PubMed ID: 12594264
[TBL] [Abstract][Full Text] [Related]
14. Activation of murine macrophages by Neisseria meningitidis and IFN-gamma in vitro: distinct roles of class A scavenger and Toll-like pattern recognition receptors in selective modulation of surface phenotype.
Mukhopadhyay S; Peiser L; Gordon S
J Leukoc Biol; 2004 Sep; 76(3):577-84. PubMed ID: 15218052
[TBL] [Abstract][Full Text] [Related]
15. BCG vaccine mediated reduction in the MHC-II expression of macrophages and dendritic cells is reversed by activation of Toll-like receptors 7 and 9.
Bakhru P; Sirisaengtaksin N; Soudani E; Mukherjee S; Khan A; Jagannath C
Cell Immunol; 2014 Jan; 287(1):53-61. PubMed ID: 24384074
[TBL] [Abstract][Full Text] [Related]
16. Mycobacterium bovis bacillus Calmette-Guérin secreting active cathepsin S stimulates expression of mature MHC class II molecules and antigen presentation in human macrophages.
Soualhine H; Deghmane AE; Sun J; Mak K; Talal A; Av-Gay Y; Hmama Z
J Immunol; 2007 Oct; 179(8):5137-45. PubMed ID: 17911599
[TBL] [Abstract][Full Text] [Related]
17. Brucella abortus inhibits major histocompatibility complex class II expression and antigen processing through interleukin-6 secretion via Toll-like receptor 2.
Barrionuevo P; Cassataro J; Delpino MV; Zwerdling A; Pasquevich KA; García Samartino C; Wallach JC; Fossati CA; Giambartolomei GH
Infect Immun; 2008 Jan; 76(1):250-62. PubMed ID: 17984211
[TBL] [Abstract][Full Text] [Related]
18. Mycobacterium tuberculosis inhibits MHC class II antigen processing in murine bone marrow macrophages.
Noss EH; Harding CV; Boom WH
Cell Immunol; 2000 Apr; 201(1):63-74. PubMed ID: 10805975
[TBL] [Abstract][Full Text] [Related]
19. Two T cell epitopes from the M5 protein of viable Streptococcus pyogenes engage different pathways of bacterial antigen processing in mouse macrophages.
Delvig AA; Robinson JH
J Immunol; 1998 Jun; 160(11):5267-72. PubMed ID: 9605123
[TBL] [Abstract][Full Text] [Related]
20. Mycobacterium tuberculosis synergizes with ATP to induce release of microvesicles and exosomes containing major histocompatibility complex class II molecules capable of antigen presentation.
Ramachandra L; Qu Y; Wang Y; Lewis CJ; Cobb BA; Takatsu K; Boom WH; Dubyak GR; Harding CV
Infect Immun; 2010 Dec; 78(12):5116-25. PubMed ID: 20837713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
